Data updated: Mar 10, 2026
LEVITRA
VARDENAFIL HYDROCHLORIDE
Approved 2003-08-19
2
Indications
--
Phase 3 Trials
22
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2003-08-19
- Routes
- ORAL
- Dosage Forms
- TABLET
LEVITRA Approval History
Loading approval history...
What LEVITRA Treats
2 FDA approvalsOriginally approved for its first indication in 2003 . Covers 2 distinct patient populations.
- Other (2)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
LEVITRA FDA Label Details
ProLEVITRA Patents & Exclusivity
Latest Patent: Jul 2027
Patents (16 active)
US8273876
Expires Jul 23, 2027
+ 6 more patents
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.